Tsubota Laboratory (TSE:4890) Stock Based Compensation: 円0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4890 Tsubota Laboratory Inc TSE:4890
61 GF Score
Price 円243.00
GF Value 円82.46
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Tsubota Laboratory Stock Based Compensation?

Tsubota Laboratory TSE:4890 -0.41% 61 Stock Based Compensation is 円0.0 Mil as of Mar. 2026. GuruFocus rates TSE:4890 with a GF Score™ of 61/100 and a GF Value™ of 円82.46 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Tsubota Laboratory's Stock Based Compensation for the six months ended in Mar. 2026 was 円0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was 円0.0 Mil.

Tsubota Laboratory Stock Based Compensation Related Terms

Tsubota Laboratory Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Tsubota Laboratory's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tsubota Laboratory Stock Based Compensation Chart

Tsubota Laboratory Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Stock Based Compensation
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Tsubota Laboratory Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4890
61GF Score
Tsubota Laboratory Inc TSE:4890
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tsubota Laboratory Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円0.0 Mil.

What does a Stock Based Compensation of 円0.0 Mil mean?
Tsubota Laboratory (TSE:4890) has a Stock Based Compensation of 円0.0 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Tsubota Laboratory and its competitors.
Is Tsubota Laboratory's Stock Based Compensation too high?
Tsubota Laboratory's current Stock Based Compensation is 円0.0 Mil. Overall, Tsubota Laboratory has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tsubota Laboratory's Stock Based Compensation compare to ABT and SYK?
Tsubota Laboratory's Stock Based Compensation of 円0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Tsubota Laboratory and its competitors. Tsubota Laboratory's current Stock Based Compensation is 円0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tsubota Laboratory stock overvalued right now?
Based on GuruFocus' analysis, Tsubota Laboratory (TSE:4890) is currently considered Significantly Overvalued. The stock's GF Value™ is 円82.46, compared to a current price of 円243.00 — trading 194.7% above its estimated fair value. The current Stock Based Compensation is 円0.0 Mil. Tsubota Laboratory's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Tsubota Laboratory (TSE:4890), the current Stock Based Compensation is 円0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tsubota Laboratory (TSE:4890) Overvalued in 2026?

Based on GuruFocus' analysis, Tsubota Laboratory stock appears to be overvalued. The current stock price of 円243.00 is trading 194.7% above its estimated GF Value™ of 円82.46. GuruFocus considers Tsubota Laboratory to be Significantly Overvalued.

Key valuation signals for TSE:4890:

  • Stock Based Compensation: 円0.0 Mil
  • GF Value™: 円82.46 vs. price of 円243.00 (194.7% above fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the TSE:4890 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tsubota Laboratory Business Description

Address 34 Shinanomachi, 304 Toshin Shinanomachi-ekimae Building, Shinjuku-ku, Tokyo, JPN, 160-0016
Tsubota Laboratory Inc is engaged in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.
61GF Score

Get the complete analysis for TSE:4890

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円243.00
Price
円82.46
GF Value